| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TUSC2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | DHRSX | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | GLCE | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | ARSB | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | MAGEA2B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | ACTR2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | NWD2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | PSMB6 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | DPH3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | CYP4A11 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
